Salivary Gland Tumor Banking and Clinical Review

Overview

About this study

The purpose of establishing the salivary gland tissue biobank is to learn how to improve our ability to diagnose and treat salivary gland tumors.  Specifically, we will be evaluating DNA, RNA, and protein in tumors and normal tissue/blood. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:    

  • Adult male and female patients, over 18 years
  • Children male and female patients, over 14 years
  • Adult pregnant woman over 18 years that are undergoing surgical treatment for salivary gland diseases.
    • Only patients with tumors involving the major or minor salivary glands that require surgical removal before normal delivery would be eligble for enrollement. 

Exclusion Criteria:   

  • Patients under the age of 14 
  • Unable to give informed consent   

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joaquin Garcia, M.D.

Contact us for the latest status

Contact information:

Nicole Tombers R.N., CCRP

(507)538-9658

Tombers.Nicole@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions